During Breast Cancer Awareness Month, The Aesthetic Foundation is highlighting the various ways that our members and donors are making an impact on patients and the specialty.
This year's cruise was our largest since 2007, with more than 150 cabins sold and over 320 attendees, including spouses, families, and guests. Among them were 120 registered plastic surgeons, including 15 current and past leaders of both the Society and Foundation. Our faculty featured 37 distinguished subject matter experts, eight of whom were first-time cruise speakers, and attendees represented ten different countries.
Spring is just around the corner, and The Aesthetic Society is already experiencing renewed energy and new growth. I wanted to answer some questions about what’s next.
Needle-free jet injector (NFJI) devices offer an alternative to traditional needle–syringe injection for administration of medications, vaccines, and other fluids.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”